Cost-effectiveness of fondaparinux vs. enoxaparin as venous thromboembolism prophylaxis in Sweden.
- Published in:
- European Journal of Health Economics, 2003, v. 4, n. 4, p. 254, doi. 10.1007/s10198-003-0175-4
- By:
- Publication type:
- Article
Works matching IS 16187598 AND DT 2003 AND VI 4 AND IP 4
Results: 14
1
2
Project of Polish guidelines for conducting pharmacoeconomic evaluations in comparison to international health economic guidelines.
- Published in:
- European Journal of Health Economics, 2003, v. 4, n. 4, p. 296, doi. 10.1007/s10198-003-0185-2
- By:
- Publication type:
- Article
3
Modeling risk-adjusted capitation rates for Umbria, Italy.
- Published in:
- European Journal of Health Economics, 2003, v. 4, n. 4, p. 304, doi. 10.1007/s10198-003-0193-2
- By:
- Publication type:
- Article
4
Should one use smokeless tobacco in smoking cessation programs?: A rational addiction approach.
- Published in:
- European Journal of Health Economics, 2003, v. 4, n. 4, p. 263, doi. 10.1007/s10198-003-0197-y
- By:
- Publication type:
- Article
5
Making economic evaluations more assessable to health care decision-makers.
- Published in:
- European Journal of Health Economics, 2003, v. 4, n. 4, p. 246, doi. 10.1007/s10198-003-0221-2
- By:
- Publication type:
- Article
6
The lag between effectiveness and cost-effectiveness evidence of new drugs: Implications for decision-making in health care.
- Published in:
- European Journal of Health Economics, 2003, v. 4, n. 4, p. 313, doi. 10.1007/s10198-003-0190-5
- By:
- Publication type:
- Article
7
An overview of the Greek pharmaceutical market.
- Published in:
- European Journal of Health Economics, 2003, v. 4, n. 4, p. 327, doi. 10.1007/s10198-003-0206-1
- By:
- Publication type:
- Article
8
Health care reform in six Central European countries: A focus on health economic requirements in the drug pricing and reimbursement processes.
- Published in:
- European Journal of Health Economics, 2003, v. 4, n. 4, p. 286, doi. 10.1007/s10198-003-0177-2
- By:
- Publication type:
- Article
9
Financial incentives and the supply of laboratory tests.
- Published in:
- European Journal of Health Economics, 2003, v. 4, n. 4, p. 279, doi. 10.1007/s10198-003-0179-0
- By:
- Publication type:
- Article
10
Testing assumptions of quality-adjusted life-year calculations: Commentary on "An Exponential Representation of Health State Utility" from M. Happich.
- Published in:
- European Journal of Health Economics, 2003, v. 4, n. 4, p. 295, doi. 10.1007/s10198-003-0183-4
- By:
- Publication type:
- Article
11
An exponential representation of health state utility.
- Published in:
- European Journal of Health Economics, 2003, v. 4, n. 4, p. 292, doi. 10.1007/s10198-003-0186-1
- By:
- Publication type:
- Article
12
A Markov model of treatment of newly diagnosed epilepsy in the UK: An initial assessment of cost-effectiveness of topiramate.
- Published in:
- European Journal of Health Economics, 2003, v. 4, n. 4, p. 271, doi. 10.1007/s10198-003-0176-3
- By:
- Publication type:
- Article
13
Measles dynamics and vaccination diffusion: A model and an application.
- Published in:
- European Journal of Health Economics, 2003, v. 4, n. 4, p. 319, doi. 10.1007/s10198-003-0192-3
- By:
- Publication type:
- Article
14
Economic burden of obesity and its complications in Germany.
- Published in:
- European Journal of Health Economics, 2003, v. 4, n. 4, p. 248, doi. 10.1007/s10198-003-0178-1
- By:
- Publication type:
- Article